492 related articles for article (PubMed ID: 21433064)
1. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses isoproterenol-induced heart failure in rats via JNK and ERK1/2 pathways.
Wang N; Guan P; Zhang JP; Li YQ; Chang YZ; Shi ZH; Wang FY; Chu L
J Cell Biochem; 2011 Jul; 112(7):1920-9. PubMed ID: 21433064
[TBL] [Abstract][Full Text] [Related]
2. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses 5-hydroxytryptamine-induced pulmonary artery smooth muscle cell proliferation via JNK and ERK1/2 pathway.
Chen XY; Dun JN; Miao QF; Zhang YJ
Pharmacology; 2009; 83(2):67-79. PubMed ID: 19052484
[TBL] [Abstract][Full Text] [Related]
3. Preventive effects of fasudil on adriamycin-induced cardiomyopathy: possible involvement of inhibition of RhoA/ROCK pathway.
Wang N; Guan P; Zhang JP; Chang YZ; Gu LJ; Hao FK; Shi ZH; Wang FY; Chu L
Food Chem Toxicol; 2011 Nov; 49(11):2975-82. PubMed ID: 21803115
[TBL] [Abstract][Full Text] [Related]
4. Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts.
Zhou H; Zhang KX; Li YJ; Guo BY; Wang M; Wang M
Clin Exp Pharmacol Physiol; 2011 Jun; 38(6):387-94. PubMed ID: 21457293
[TBL] [Abstract][Full Text] [Related]
5. Rho kinase inhibition by fasudil suppresses lipopolysaccharide-induced apoptosis of rat pulmonary microvascular endothelial cells via JNK and p38 MAPK pathway.
Liu H; Chen X; Han Y; Li C; Chen P; Su S; Zhang Y; Pan Z
Biomed Pharmacother; 2014 Apr; 68(3):267-75. PubMed ID: 24406296
[TBL] [Abstract][Full Text] [Related]
6. RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism.
Na W; Peng G; Jianping Z; Yanzhong C; Shengjiang G; Li C
Toxicol Ind Health; 2012 Oct; 28(9):831-9. PubMed ID: 22072613
[TBL] [Abstract][Full Text] [Related]
7. Fasudil hydrochloride hydrate, a Rho-kinase (ROCK) inhibitor, suppresses collagen production and enhances collagenase activity in hepatic stellate cells.
Fukushima M; Nakamuta M; Kohjima M; Kotoh K; Enjoji M; Kobayashi N; Nawata H
Liver Int; 2005 Aug; 25(4):829-38. PubMed ID: 15998434
[TBL] [Abstract][Full Text] [Related]
8. The Rho kinase inhibitor, fasudil, ameliorates diabetes-induced cardiac dysfunction by improving calcium clearance and actin remodeling.
Lai D; Gao J; Bi X; He H; Shi X; Weng S; Chen Y; Yang Y; Ye Y; Fu G
J Mol Med (Berl); 2017 Feb; 95(2):155-165. PubMed ID: 27576917
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of favorable effects of Rho kinase inhibition on myocardial remodeling and systolic function after experimental myocardial infarction in the rat.
Mera C; Godoy I; Ramírez R; Moya J; Ocaranza MP; Jalil JE
Ther Adv Cardiovasc Dis; 2016 Feb; 10(1):4-20. PubMed ID: 26490279
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase inhibition by fasudil ameliorates diabetes-induced microvascular damage.
Arita R; Hata Y; Nakao S; Kita T; Miura M; Kawahara S; Zandi S; Almulki L; Tayyari F; Shimokawa H; Hafezi-Moghadam A; Ishibashi T
Diabetes; 2009 Jan; 58(1):215-26. PubMed ID: 18840783
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Rho-kinase Attenuates Left Ventricular Remodeling Caused by Chronic Intermittent Hypoxia in Rats via Suppressing Myocardial Inflammation and Apoptosis.
Wang ZH; Zhu D; Xie S; Deng Y; Pan Y; Ren J; Liu HG
J Cardiovasc Pharmacol; 2017 Aug; 70(2):102-109. PubMed ID: 28437280
[TBL] [Abstract][Full Text] [Related]
12. [The expression of Rho/Rho kinase of cardiac muscle in heart failure rats caused by pressure overload and the intervention of fasudil].
Zhang M; Qu C; Zeng DY
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Jan; 33(1):73-6. PubMed ID: 15924788
[TBL] [Abstract][Full Text] [Related]
13. Fasudil protects against isoproterenol-induced myocardial infarction in mice via inhibiting Rho/ROCK signaling pathway.
Zhou FT; Ma K
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5659-5667. PubMed ID: 32495901
[TBL] [Abstract][Full Text] [Related]
14. Chronic treatment with an oral rho-kinase inhibitor restores erectile function by suppressing corporal apoptosis in diabetic rats.
Li WJ; Park K; Paick JS; Kim SW
J Sex Med; 2011 Feb; 8(2):400-10. PubMed ID: 20233282
[TBL] [Abstract][Full Text] [Related]
15. Rho-Kinase inhibitor fasudil suppresses high glucose-induced H9c2 cell apoptosis through activation of autophagy.
Gao H; Hou F; Dong R; Wang Z; Zhao C; Tang W; Wu Y
Cardiovasc Ther; 2016 Oct; 34(5):352-9. PubMed ID: 27333569
[TBL] [Abstract][Full Text] [Related]
16. Fasudil, a Rho kinase inhibitor, promotes the autophagic degradation of A53T α-synuclein by activating the JNK 1/Bcl-2/beclin 1 pathway.
Liu FT; Yang YJ; Wu JJ; Li S; Tang YL; Zhao J; Liu ZY; Xiao BG; Zuo J; Liu W; Wang J
Brain Res; 2016 Feb; 1632():9-18. PubMed ID: 26683082
[TBL] [Abstract][Full Text] [Related]
17. Fasudil hydrochloride protects neurons in rat hippocampal CA1 region through inhibiting GluR6-MLK3-JNKs signal pathway.
Wei XE; Zhang FY; Wang K; Zhang QX; Rong LQ
Cell Biochem Biophys; 2014 Sep; 70(1):415-21. PubMed ID: 24793642
[TBL] [Abstract][Full Text] [Related]
18. Fasudil, a Rho-kinase inhibitor, protects against excessive endurance exercise training-induced cardiac hypertrophy, apoptosis and fibrosis in rats.
Ho TJ; Huang CC; Huang CY; Lin WT
Eur J Appl Physiol; 2012 Aug; 112(8):2943-55. PubMed ID: 22160250
[TBL] [Abstract][Full Text] [Related]
19. [Effects of fasudil on isoproterenol induced cardiac hypertrophy in rats].
Cheng JK; Sun XH; Gao LP; Li L
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2016 May; 32(5):414-418. PubMed ID: 29931844
[TBL] [Abstract][Full Text] [Related]
20. Long-term administration of fasudil improves cardiomyopathy in streptozotocin-induced diabetic rats.
Guan SJ; Ma ZH; Wu YL; Zhang JP; Liang F; Weiss JW; Guo QY; Wang JY; Ji ES; Chu L
Food Chem Toxicol; 2012 Jun; 50(6):1874-82. PubMed ID: 22429817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
